{"podcast":{"title":"The BioHub - by Avetix","slug":"the-biohub-by-avetix-7252289","podcast_index_feed_id":7252289,"rss_url":"https://anchor.fm/s/f0076084/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/max-brennan4","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1775724702970-e7a36a5e3cf58.jpg","author":"Max Brennan - Biotech HeadHunter","episode_count":230,"summary":"Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.","last_synced_at":"2026-07-21T04:19:24.893516+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289"},"episode":{"title":"Episode 171 - Amin & Chad - Resvita Bio CEO & CTO","slug":"episode-171-amin-chad-resvita-bio-ceo-cto","published_at":"2026-05-11T11:11:15+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-171-amin-chad-resvita-bio-ceo-cto","show_page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289","url":"https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-171---Amin--Chad---Resvita-Bio-CEO--CTO-e3j6khp","audio_url":"https://anchor.fm/s/f0076084/podcast/play/119803897/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-11%2F423903879-44100-2-507e64c068ced.mp3","summary":"In this episode of The BioHub Podcast , Max sits down with Amin Zargar, CEO of ResVita Bio, and Chad Miller, the company’s Chief Technology Officer. ResVita is developing a new class of treatments for skin diseases using engineered bacteria to deliver continuous protein therapy directly on the skin — an approach designed to transform how chronic dermatological conditions are treated. Amin brings deep expertise in synthetic biology from Jay Keasling’s lab at UC Berkeley, while Chad’s background spans protein design research in David Baker’s lab and founding Nosis Bio. In this conversation, we talk about how ResVita was founded, the science behind continuous protein therapy, why Chad joined the mission, and what’s next as the company moves toward the clinic.","meta_description":"In this episode of The BioHub Podcast , Max sits down with Amin Zargar, CEO of ResVita Bio, and Chad Miller, the company’s Chief Technology Officer. ResVi…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2025,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-171-amin-chad-resvita-bio-ceo-cto/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-171-amin-chad-resvita-bio-ceo-cto.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}